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TYPE I COLLAGEN IS THE MOST abundant protein in living organisms. It is mainly distributed in the connective tissues (bone, tendon, blood vessels, and skin) and plays an important role in maintaining the structural integrity and elasticity of these tissues. Tropocollagen, consisting of two ␣1 chains and one ␣2 chain, is a basic molecular unit and further aggregates to stronger forms of collagen fibrils and collagen fibers (1, 11) . In wound healing, newly synthesized type I collagens replace damaged cells and maintain the structural strength. However, overproduction of collagen caused by the imbalance between collagen synthesis and degradation results in tissue fibrosis, followed by organ failure (9) . In addition, fibrosis may be due not only to the accumulation of collagen but also to the collapse of the renal parenchyma, according to the "balloon" hypothesis (12) . Although various different fibrogenic factors have been documented, it is widely accepted that transforming growth factor-␤ (TGF-␤) and its downstream Smad signaling play an essential role for tissue fibrosis (19) . Tissue fibrosis is a major pathological lesion which finally leads to organ failure and is closely related to the progression of various diseases, such as chronic kidney disease (diabetic nephropathy, glomerulonephritis, and nephrosclerosis), cirrhosis, pulmonary fibrosis, cardiac fibrosis, and scleroderma (10, 26, 28) . Since there are no antifibrotic drugs that effectively prevent fibrosis, the development of such drugs is strongly desired. One of the major hindrances to the development of antifibrotic drugs is that there are no useful animal models in which it is possible to detect fibrosis sensitively in a short period of time. Several conventional methods are used for the evaluation of tissue fibrosis, such as the measurement of collagen-specific hydroxyproline content (4), mRNA quantification of fibrotic proteins, and histopathological methods for Masson's trichrome (2) or Sirius red staining area (19) . However, these methods have undesirable features, such as low sensitivity and lack of quantitative linearity.
Luciferase assays have a number of merits, including high sensitivity, linearity over a wide range, a simple methodology requiring only the addition of substrate to tissue lysates, and no need for expensive detection instruments, unlike real-time PCR. Transgenic (Tg) mice harboring a luciferase gene under the control of a promoter and a far upstream enhancer of ␣ 2 (I) collagen have already been generated (6) . However, in many ways rats are more similar physiologically to humans than mice and are ideal animals for modeling human diseases.
Therefore, we generated Tg rats carrying a luciferase reporter gene under the control of the 5=-flanking region of rat ␣ 1 (I) collagen (Col1a1-Luc Tg rats) and rat ␣ 2 (I) collagen (Col1a2-Luc Tg rats) and evaluated the antifibrotic effects of a TGF-␤ type I receptor kinase (ALK5) inhibitor and ANG II type 1 receptor blocker (ARB) using these Tg rats.
MATERIALS AND METHODS

Animals and treatments.
All the animal experiments were performed according to the Laboratory Animal Guidelines of Daiichi Sankyo. Transgenic founders were generated by the injection of a transgene into zygotes, which were bred and maintained in a heterozygous state. The animals were kept under conditions of a 12:12-h light-dark cycle at 23 Ϯ 3°C with standard chow pellets and tap water ad libitum. The renal interstitial fibrosis model was performed as described below. The left ureters of Col1a1-Luc Tg rats or Col1a2-Luc Tg rats were ligated, and the kidneys were harvested after 0, 3, 7, or 14 days of unilateral ureteral obstruction (UUO). Then, the hydroxyproline content, luciferase activities, and type I collagen mRNA level were evaluated. Olmesartan medoxomil (ARB; Daiichi Sankyo) and SB-431542 (17) (ALK5 inhibitor, synthesized at Daiichi Sankyo) were suspended in 0.5% carboxymethylcellulose and orally administered to Col1a1-Luc Tg rats 1 day before UUO and every day thereafter. After 3 days of UUO, the kidneys were harvested and the luciferase activities were measured.
Generation of Col1a1-Luc Tg rats. PCR primers were designed based on the rat exon 1 sequence of ␣ 1(I) collagen (GenBank no. J04464). PCR amplification was performed with a Wistar rat genome as a template using a forward primer (TGACTGTCCTGGAAT-TCACT) and a reverse primer (TAGGAAACTCTGAAGCCCTG). Then, nested PCR was performed with the first PCR product as a template using a forward primer (CTATAGACCAGGCTAGCCTC) and a reverse primer (GCTTCTTGTGGAATGTAGGG). After this 860-bp PCR fragment was identified as a target gene by sequence analysis, it was labeled with digoxygenin (PCR DIG probe synthesis kit, Boehringer Mannheim) and used as a DNA probe. The 5=-flanking region of ␣ 1(I) collagen from Ϫ14,269 to ϩ371 bp was cloned from a rat genomic library (MoBiTec, Göttingen, Germany). After automatic subcloning into a pPS vector, the 5=-flanking region of ␣ 1(I) collagen from Ϫ14,247 to ϩ113 bp was recloned into a luciferase reporter vector (pGV-B2, Toyo B-Net, Tokyo, Japan) according to the scheme described in Fig. 1A . PCR was performed for the amplification of the 5=-flanking region of ␣1(I) collagen from Ϫ14.2 to Ϫ12.4 kb by a forward primer containing a MluI site (CCCACGCGTGC-CTGGTCTACATAGTGAGT) and a reverse primer containing an AatII site (GACGTCCACAGGTATTGGATATCTCC) and the region from Ϫ1.4 to ϩ0.1 kb by a forward primer (ACAGCTCTGAA-GACGGCTGT) and a reverse primer containing a XhoI site (TT-TCTCGAGCTAGACCCTAGACATGTAGA). The PCR products were subcloned into pGEM-T Easy vector (Promega, Madison, WI), digested with MluI/AatII or XhoI/AatII, and the digested fragments were then recloned into the pGV-B2 vector. Furthermore, the EcoRV/ AatII fragment in the 5=-flanking region of ␣1(I) collagen from Ϫ12.4 to Ϫ1.4 kb was recloned, and this constructed plasmid was finally linearized by digestion with NotI/SalI to remove the unwanted region containing the bacterial replication origin and a drug-resistant gene. The DNA construct was injected into 233 zygotes and transferred into 8 pseudopregnant female recipients, which resulted in the birth of 59 offspring rats. Two founder rats that had luciferase activity in a tail sample were named 453-5 and 455-2. Since the 453-5 line had a higher luciferase activity, it was crossed with Wistar or Wistar-Kyoto rats in a heterozygous state and used in the following experiments.
Generation of Col1a2-Luc Tg rats. PCR primers were designed based on the rat promoter region of ␣ 2(I) collagen (GenBank no. X66209). PCR amplification was performed with a Wistar rat genomic template using a forward primer (AAGAAGCCCTGTAGC-CACGT) and a reverse primer (CAACAGAGTTCGCGTATCCA). After a 350-bp PCR fragment was identified as the target gene by sequence analysis, it was labeled with digoxygenin and used as a DNA probe. The 5=-flanking region of ␣ 2(I) collagen from Ϫ9,217 to ϩ4,520 bp was cloned from a rat genomic library (Stratagene, La Jolla, CA). After subcloning into pGEM-T Easy vector in the NotI site, the 5=-flanking region of ␣ 2(I) collagen from Ϫ7,585 to ϩ89 bp was recloned into the pGV-B2 vector according to the scheme described in Fig. 1B . PCR was performed for the amplification of the 5=-flanking region of ␣ 2(I) collagen from Ϫ0.5 to ϩ0.1 kb by a forward primer (GTCACCCTCCACCTCTCACA) and a reverse primer containing a HindIII site (CACCAGCGGAGGTATCACCTA-AGCTT). The PCR products were subcloned into pGEM-T Easy vector, digested with XhoI/HindIII, and the digested fragment was then recloned into the pGV-B2 vector. Furthermore, the KpnI/XhoI fragment in the 5=-flanking region of ␣ 2(I) collagen from Ϫ7.6 to Ϫ0.5 kb was recloned, and this constructed plasmid was finally linearized by digestion with NotI/BamHI to remove the unwanted region containing the bacterial replication origin and a drug-resistant gene. The DNA construct was injected into 323 zygotes and transferred into 11 pseudopregnant female recipients, which resulted in the birth of 88 offspring rats. Eight lines of these rats had luciferase activity in a tail sample. The Tg line with the highest luciferase activity was crossed with Wistar rats in a heterozygous state and used in the following experiments.
Southern blot analysis. The luciferase-coding region in the pGV-B2 vector was cut out with NcoI/HincII, labeled with 32 P (Megaprime DNA Labeling System, Amersham Pharmacia Biotech, Piscataway, NJ), and used as a probe for detection of the luciferase gene. Genomic DNA samples of liver or tail were digested with restriction enzymes, electrophoresed through an agarose gel, depurinated in 0.25 N HCl, and transferred to a positively charged nylon membrane (Hybond-XL, Amersham Pharmacia Biotech) using an alkaline transfer buffer. After hybridization, the membrane was washed several times and exposed to X-ray film (BioMax MS, Kodak, Rochester, NY) at 4°C for 1 wk.
Measurement of luciferase activity. The luciferase activities were measured with a Picagene BrillianStar-LT Luminescence Kit (Toyo B-Net, Tokyo, Japan) according to the manufacturer's instructions. Briefly, 5 l of the supernatant of the tissue homogenates and 100 l of luciferase substrate were added to each well of a microtiter plate (B&W Isoplate, Perkin-Elmer Wallac, Gaithersburg, MD), and then the luminescence was measured using a Wallac ARVO HTS-1420 multilabel counter (PerkinElmer Life Sciences, Boston, MA). The luciferase activity was quantified using the standard curve of a luciferase enzyme (Toyo B-Net). The amount of protein in the sample was measured by the BCA method (Micro BCA Protein Assay Kit, Pierce, Rockford, IL), and the luciferase activity was then adjusted for the amount of protein.
RNA isolation and real-time RT-PCR. The total RNA was extracted from the kidney by the combined guanidinium thiocyanate and silica membrane method (Nucleospin RNA II, Macherey-Nagel, Düren, Germany). The RNA concentrations were determined spectrophotometrically, and the total RNA was reverse transcribed using a PrimeScript RT reagent kit (Takara Bio, Otsu, Japan). Quantitative real-time PCR was performed using SYBR Premix Ex Taq II (Takara Bio) with predesigned primer sets for SYBR green PCR (Takara Bio), and the fluorescence of the PCR products was detected using an ABI PRISM 7900HT (Applied Biosystems, Tokyo, Japan).
Hydroxyproline determinations. The hydroxyproline content was quantitated colorimetrically from tissue samples by the chloramine T method as described by Bergheim et al. (3) . In brief, tissue samples (50 -100 mg) were weighed and hydrolyzed in 1 ml of 6 N HCl at 100°C for 24 h. The hydrolysate was cooled, neutralized with an equal amount of 6 N NaOH, and centrifuged at 13,000 g for 12 min. Forty microliters of the supernatant was added to a microtiter plate and incubated with 25 l of chloramine T solution [1 part 7% chloramine T and 4 parts citrate/acetate buffer (pH 6.0, 695 mM sodium acetate, 128 mM trisodium citrate, and 29 mM citric acid, with 38.5% isopropanol)] at room temperature for 10 min. Then, 150 l of Ehrlich's solution (1.4 M dimethylaminobenzaldehyde with 20% perchloric acid and 67% isopropanol) was added and incubated at 65°C for 20 min. After cooling, the absorbance was read at 560 nm. The hydroxyproline content was quantified using a standard curve of high-purity hydroxyproline (Wako Pure Chemicals, Osaka, Japan) and adjusted for the tissue weight.
Sirius red staining. Kidney sections were stained with Sirius red as described by López-De León et al. (20) . In brief, rat kidneys were snap-frozen in liquid nitrogen using OTC compound (Sakura Finetek, Torrance, CA), sliced at a thickness of 5 m using a cryostat microtome, and placed on a MAS-coated glass slide (Matsunami Glass, Osaka, Japan). After being air-dried, the section was fixed in a mixture of 4% paraformaldehyde and 0.2% glutaraldehyde for 15 min at room temperature and immersed for 1 h in 0.1% Sirius red (Direct red 80, Sigma-Aldrich, St. Louis, MO) in saturated aqueous solution of picric acid. The section was counterstained with 0.1% fast green FCF (Wako Pure Chemicals). Then, the section was rinsed for 2 min in 0.01 N HCl to remove any unbound dyes, dehydrated in an alcohol series, cleaned with xylene, and mounted in Mount-Quick (Daido Sangyo, Tokyo, Japan).
Immunohistochemistry. Frozen sections (5 m in thickness) were fixed with 4% paraformaldehyde for ␣-smooth muscle actin (␣-SMA) and type I collagen immunostaining, or with cold acetone for luciferase immunostaining. The endogenous peroxidase activity was inactivated by incubation with 3% hydrogen peroxide in methanol. After blocking in 2.5% normal horse serum (Vector Laboratories, Burlingame, CA), the sections were incubated with goat anti-type I collagen antibody (Southern Biotechnology Associates, Birmingham, UK), rabbit anti-luciferase antibody (Medical & Biological Laboratories, Nagoya, Japan), or mouse monoclonal anti-␣-SMA antibody (clone 1A4, DakoCytomation, Glostrup, Denmark) for 1 h at room temperature. After washing, the sections were incubated with horseradish peroxidase-conjugated secondary antibody (Histofine Simple Stain MAX PO, Nichirei Biosciences, Tokyo, Japan), washed with PBS, and then color-developed with 3,3=-diaminobenzidine (Nichirei Biosciences). In the event of weak staining in the luciferase immunostaining, the signal was amplified by anti-horseradish peroxidase antibody (clone 2H11, Abcam, Tokyo, Japan). A concise summary of the immunofluorescence staining method is as follows. A frozen section (5 m in thickness) was fixed with acetone, blocked with Image-iT FX signal enhancer (Molecular Probes/Invitrogen, Carlsbad, CA), and incubated with rabbit anti-luciferase antibody and/or mouse monoclonal anti-␣-SMA antibody. After washing, the section was incubated with Alexa Fluor 488-labeled goat anti-rabbit IgG antibody and/or Alexa Fluor 555-labeled goat anti-mouse IgG antibody (Molecular Probes/Invitrogen). After washing, the section was mounted with Fluoromount/Plus (Diagnostic Biosystems, Pleasanton, CA) and observed with a fluorescence microscope.
Primary culture. Hepatocytes were isolated from the liver of a male Col1al-Luc Tg rat at 12 wk of age by the collagenase perfusion method, seeded on a collagen type I-coated 24-well microplate, and cultured in hepatozyme-SFM (Invitrogen). The medium was replaced into flesh medium 24 h after seeding, and another 24 h later, the cells were harvested. Vascular smooth muscle cells (VSMC) were isolated by the explant method from a thoracic aorta of a male Col1al-Luc Tg rat at 11 wk of age. The blood vessel was cut into 2-to 3-mm square pieces and put inside of the aorta onto a gelatin-coated culture dish. Cells were cultured in DMEM/10% FCS medium containing kanamycin (100 g/ml) and amphotericin B (1 g/ml). Primary cultures Values of hydroxyproline are expressed as the mean of 4 female Wistar rats at 6 wk of age. Values of the luciferase activities in Col1a1-Luc Tg rats are expressed as the mean of 3 female rats at 7 wk of age. Values of the luciferase activities in Col1a2-Luc Tg rats are expressed as the mean of 1 male and 2 female rats at 5 wk of age. Table 1 . C: primary cultured cells of Col1a1-Luc Tg rat. Detailed values and experimental data are described in Table 2 . Values of mRNA expression and luciferase activity are expressed as the mean of 3-5 replicates. Hepatocytes were isolated by the collagenase perfusion method, and the experiment was performed at primary cultures (P1). Vascular smooth muscle cells (VSMC) and fibroblasts were isolated by the explant method from aorta and skin, respectively, and the experiment was performed at P2.
(P1) were passaged and harvested at 60 -80% confluence of P2. Fibroblasts were isolated by the explant method from a piece of back skin of a male Col1al-Luc Tg rat at 11 wk of age. Cells were cultured in DMEM/10% FCS medium containing kanamycin and amphotericin B and harvested at 60 -80% confluence of P1. These cells were harvested with LyEX1 buffer (Toyo B-Net) for luciferase assay or with lysis buffer of Nucleospin RNA II kit for mRNA analysis.
In vitro assay using isolated glomeruli. Glomeruli were isolated from five male Col1a1-Luc Tg rats by the modified sieving method according to Misra (21) . The glomeruli trapped on a 53-m sieve after passing through a series of graded sieves (250, 180, 150 m) were suspended in DMEM/0.2% FCS medium. Then, 150 -200 glomeruli were seeded onto a 96-well microtiter plate in 150 l medium/well. The compounds were dissolved in dimethylsulfoxide and added to each well. Thirty minutes after addition of the compounds, human TGF-␤1 (10 ng/ml, R&D Systems, Minneapolis, MN) or ANG II (100 nM, 10,000 nM, Peptide Institute, Osaka, Japan) was added to each well. The plate was then incubated at 37°C for 48 h with 5% CO2. The glomeruli were transferred into microtubes, washed with PBS, and lysed by a freeze-thaw procedure in 50 l of GLO lysis buffer (Promega, Madison, WI). The luciferase activities were measured in the glomerular lysate.
Statistical analysis.
Values are expressed as means Ϯ SE. The statistical analysis was performed by Student's t-test for a comparison of two groups and by the Dunnett test for a comparison of three or more groups. All calculations were done using SAS System Release 8.2 (SAS Institute). Values of P Ͻ 0.05 were considered statistically significant.
RESULTS
A schematic diagram of the plasmid construction is shown in Fig. 1 (a detailed protocol is given in MATERIALS AND METHODS) . We cloned the 5=-flanking region of ␣ 1 (I) collagen from Ϫ14.3 to ϩ 0.4 kb from a rat genome library and recloned the region from Ϫ14.2 to ϩ0.1 kb into the pGV-B2 vector. The digestion patterns of the constructed Col1a1-Luc plasmid with restriction enzymes showed a 19.2-kb fragment of the AatII digest and 11.0-and 8.2-kb fragments of the AatII/EcoRV digest, which corresponded to the predicted sizes (Fig. 1A) . We also cloned the 5=-flanking region of ␣ 2 (I) collagen from Ϫ9.3 to ϩ4.6 kb from a rat genome library and recloned the region from Ϫ7.6 to ϩ0.1 kb into the pGV-B2 vector. The digestion patterns of Fig. 4 . Correlation between hydroxyproline and luciferase activity or ␣1(I) collagen mRNA level in a unilateral ureteral obstruction (UUO) model. Male Col1a1-Luc Tg rats at 10 wk of age were subjected to UUO or sham operation and killed 0, 3, 7, or 14 days after UUO. A: hydroxyproline. B: luciferase activity. C: ␣1(I) collagen mRNA using ␤-actin as an internal standard. D: ␣2(I) collagen mRNA using ␤-actin as an internal standard. E: correlation between hydroxyproline and luciferase activity. F: correlation between hydroxyproline and ␣1(I) collagen mRNA. Values are means Ϯ SE expressed as the ratio of the obstructed kidney to the contralateral normal kidney of 3-5 rats. **P Ͻ 0.01, ***P Ͻ 0.001 vs. day 0 (sham-operated control).
the constructed Col1a2-Luc plasmid with restriction enzymes showed a 12.4-kb fragment of the KpnI digest and 7.1-and 5.3-kb fragments of the KpnI/XhoI digest, which corresponded to the predicted sizes (Fig. 1B) .
The diagrams of the transgenes and Southern blot analysis are shown in Fig. 2 . The DNA construct of the Col1a1-Luc Tg rat had the 5=-flanking region of rat ␣ 1 (I) collagen from Ϫ14,247 to ϩ113 bp containing 14 CAGACA sequences as Smad binding elements (Ϫ13,821, Ϫ13,531, Ϫ11,416, Ϫ10,702, Ϫ10,468, Ϫ9,487, Ϫ9,271, Ϫ8,796, Ϫ7,489, Ϫ7,283, Ϫ6,624, Ϫ5,157, Ϫ2,256, and Ϫ2,226 bp relative to the transcriptional start site) and was linked to a firefly luciferase reporter gene. Also, the DNA construct of Col1a2-Luc Tg rat had the 5=-flanking region of rat ␣ 2 (I) collagen from Ϫ7,585 to ϩ89 bp containing five CAGACA sequences as Smad binding elements (Ϫ4,985, Ϫ4,636, Ϫ4,371, Ϫ2,455, and Ϫ2,451 bp relative to the transcriptional start site) and was linked to a firefly luciferase reporter gene (Fig. 2A) . First, we performed a Southern blot analysis of Col1a1-Luc Tg rats using F0, F5, and F7 generations of the 453-5 line and the F3 generation of the 455-2 line. However, all lanes showed smear patterns (Fig. 2B, lanes 1-7) . Since degradation of stock samples could cause the smearing patterns, we performed the analysis again using tail and liver samples of currently breeding rats (453-5 line) which were over the eighth generation. There were 15.2-kb fragment of the AseI/HpaI digest and 5.4-kb fragment of the XbaI digest, which corresponded to the predicted sizes (Fig.  2C) . Southern blot analysis of a Col1a2-Luc Tg rat using tail samples of the F0 generation showed an 8.1-kb fragment of BglII/BamHI digest, a 5.6-kb fragment of the HpaI digest, and a 3.6-kb fragment of the HincII digest, which corresponded to the predicted sizes (Fig. 2B, lanes 8 -11) .
The tissue hydroxyproline content and luciferase activity of Col1a1-Luc Tg rats and Col1a2-Luc Tg rats are shown in Table 1 . Both lines had high luciferase activities in collagen-rich tissues such as the tail and lung. There was a very high correlation between the luciferase activity and hydroxyproline in Col1a1-Luc Tg rats (r ϭ 0.99, Fig. 3A) . Although there was a high correlation between the luciferase activity and hydroxyproline in Col1a2-Luc Tg rats (r ϭ 0.94, Fig. 3B ), overall their luciferase activities were much lower than those in Col1a1-Luc Tg rats. Therefore, the following experiments were performed using Col1a1-Luc Tg rats. It may be insufficient to evaluate with only gene expression analysis of whole tissue, since whole tissue is the mixture of various levels of collagenexpressed cells. Therefore, we evaluated the correlations between luciferase activity and mRNA expression by using vascular smooth muscle cells and dermal fibroblasts as collagen-expressing cells and hepatocytes as nonexpressing (only weakly expressing) cells. Luciferase activities in homogeneous populations of cells correlated well with ␣1(I) collagen mRNA expression (r ϭ 0.97, Table 2 , Fig. 3C) .
We evaluated the renal hydroxyproline content, luciferase activity, and type I collagen mRNA level in a UUO model (Fig. 4) .
The renal hydroxyproline content showed only a 1.3-fold increase after 3 days of UUO, and significant increases after 7 and 14 days of UUO (2.1-and 3.4-fold, respectively) (Fig. 4A) . In contrast, the renal luciferase activity increased 5.4-fold after even 3 days of UUO and further increased after 7 and 14 days in a time-dependent manner (6.5-and 9.5-fold, respectively) (Fig. 4B) . On the other hand, ␣ 1 (I) collagen mRNA increased 5.7-fold after 3 days of UUO (similar increased level as luciferase, but not significant relative to the day 0 group), reached a peak of 19-fold after 7 days and decreased gradually to 12-fold after 14 days (Fig. 4C) . The expression pattern of ␣ 2 (I) collagen mRNA was similar to that of ␣ 1 (I) collagen mRNA (Fig. 4D) . The renal luciferase activity had a high correlation with the hydroxyproline in the UUO model over the experimental period (r ϭ 0.91, Fig. 4E ). However, ␣ 1 (I) collagen mRNA had only moderate correlation with hydroxyproline (r ϭ 0.62, Fig. 4F ).
Histological stainings of contralateral normal kidney sections are shown in Fig. 5 , A (Sirius red), C (type I collagen), E (luciferase), and G (␣-SMA). The perivascular areas surrounding the interlobular and larger arteries were strongly stained, and the peritubular areas were weakly stained with Sirius red staining in normal kidney sections (Fig. 5A) . Type I collagen immunostaining showed almost the same staining pattern as Sirius red staining (Fig. 5C) . The smooth muscle cells of the interlobular and larger arteries were strongly stained, and the tubular epithelial cells were weakly stained by luciferase immunostaining (Fig. 5E) , in which the luciferase-positive cells were located close to the type I collagen staining area. Meanwhile, not only the artery but also the vein smooth muscle cells were strongly stained by ␣-SMA immunostaining (Fig. 5G) . Histological stainings of obstructed kidney sections at day 7 after UUO are shown in Fig. 5 , B (Sirius red), D (type I collagen), F (luciferase), and H (␣-SMA). The tubulointerstitial areas were strongly stained with Sirius red staining in UUO kidney sections (Fig. 5B) . Type I collagen immunostaining showed almost the same staining pattern as Sirius red staining (Fig. 5D) . Some tubular epithelial cells and tubulointerstitial cells were strongly stained by luciferase immunostaining (Fig.  5F ). Some tubular epithelial cells and a widespread area of tubulointerstitium were strongly stained by ␣-SMA immunostaining (Fig. 5H) .
Immunofluorescence of contralateral normal kidney sections is shown in Fig. 6, A (luciferase) , B (␣-SMA), and C (luciferase and ␣-SMA). The tubular cells were weakly fluoresced green by luciferase immunofluorescence (Fig. 6A) , the vascular smooth muscle cells were fluoresced red by ␣-SMA immunofluorescence (Fig. 6B) , and were not colocalized (Fig. 6C) . Immunofluorescence of obstructed kidney sections at day 7 after UUO is shown in Fig. 6 , D (luciferase), E (␣-SMA), and F (luciferase and ␣-SMA). Some tubular cells and tubulointerstitial cells were strongly fluoresced green by luciferase immunofluorescence (Fig. 6D) , and tubular cells and tubulointerstitial cells in addition to vascular cells were fluoresced red by ␣-SMA immunofluorescence (Fig. 6E) , some of which were colocalized and are shown as yellow in the merged image (Fig.  6F) . These results indicated that some ␣-SMA-positive tubular cells and interstitial cells produced type I collagen and caused fibrosis in a UUO model.
We evaluated the renal antifibrotic effects of ARB and an ALK5 inhibitor in a UUO model using Col1a1-Luc Tg rats (Fig. 7) . The ALK5 inhibitor SB-431542 at 100 mg/kg body wt inhibited the luciferase activity by ϳ60%. The ARB olmesartan medoxomil at doses of 3 and 10 mg/kg body wt also significantly inhibited luciferase activity, while the inhibition rate was ϳ30%, half that of ALK5 inhibition. These results suggest that ANG II as well as TGF-␤ play a critical role in renal fibrosis.
Subsequently, we evaluated the renal fibrotic effects of TGF-␤1 and ANG II in isolated glomeruli using Col1a1-Luc Tg rats. Luciferase activity was increased by TGF-␤1, whereas there were no obvious changes with ANG II (Fig. 8A) . Moreover, the increase in luciferase activity induced by TGF-␤1 was suppressed by SB-431542, but not by olmesartan (Fig. 8B) .
These results raise the possibility that TGF-␤ is the main mediator of renal fibrosis and ANG II probably contributes to renal fibrosis by upregulation of TGF-␤ expression, not by action against the TGF-␤ signaling pathway, including ALK5 and Smad, or by direct action independent of TGF-␤.
DISCUSSION
We generated two lines of collagen reporter Tg rats, Col1a1-Luc Tg and Col1a2-Luc Tg. The tissue luciferase activities were highly correlated with hydroxyprolines of corresponding tissues in both lines. However, the tissue luciferase activities in Col1a1 Tg rats were generally much higher than those in Col1a2 Tg rats. The gene expression of type I collagen is mainly regulated by TGF-␤/Smad signaling (5), and CAGACA was identified as a Smad binding element in TGF-␤-responsive genes such as PAI-1 and JunB (8, 15) . One reason for the low luciferase activity in Col1a2-Luc Tg rats may be that the length of the 5=-flanking region in Col1a2-Luc Tg rats was about half of that in Col1a1-Luc Tg rats and the number of CAGACA sequences in Col1a2-Luc Tg rats was only about one-third of those in Col1a1-Luc Tg rats. Another reason may be that the transgene in Col1a2-Luc Tg rats had an absence of some critical transcriptional regulatory regions such as the far-upstream enhancer region from Ϫ19.5 to Ϫ13.5 kb in ␣ 2 (I) collagen genes reported in mice (6) . Consequently, we selected Col1a1-Luc Tg rats as a model for the short-term evaluation of fibrosis.
We could detect the localization of luciferase in interstitial fibroblasts, as well as in tubules (Fig. 6 ). There is not enough time to evaluate extracellular matrix accumulation completely ϳ1 wk after UUO, and extracellular matrix is traditionally evaluated at a later time point. At a later time point, the collagen-producing cells have already mainly resided in a tubular interstitial space, and their origins are thought to be mostly from resident fibroblasts, tubular cells, and bone marrow cells (14) . By the use of Col1a1-Luc Tg rat, we could perform immunohistochemical evaluation in the short-term, even 1 wk after UUO. Furthermore, tubular cells were ␣-SMA/luciferase double positive, indicating that they could undergo an epithelial-to-mesenchymal transition (EMT) and produce collagen in their innate site without migrating into interstitium. In our short-term evaluation, we possibly observed a preliminary step of EMT before migration of cells into the interstitium. An important finding from our study is that tubular cells can produce collagen as soon as they undergo EMT and migrate into Fig. 7 . Renal antifibrotic effect of SB-431542 (A) and olmesartan medoxomil (B). Male Col1a1-Luc Tg rats at 11 to 12 wk of age were subjected to UUO and killed 3 days after UUO. Both compounds were orally administered 1 day before UUO and every day thereafter. Control group, contralateral normal kidney of vehicle-treated rats; vehicle group, obstructed kidney of vehicletreated rats; other groups, obstructed kidney of compound-treated rats. Values are means Ϯ SE of 5-6 rats. ###P Ͻ 0.001 vs. control. *P Ͻ 0.05 vs. vehicle.
an interstitial space; namely, they can produce collagen before they reach the interstitial space.
Generally, collagen expression in UUO model is increased in a time-dependent manner. Compared with real-time PCR, luciferase activity and hydroxyproline can indicate the increase in collagen expression, especially at day 14 after UUO. There is a different turnover rate between mRNA and protein, causing a lag at the peak times of their expression. That would be why there was a small correlation between ␣ 1 (I) collagen mRNA level and hydroxyproline in this study. Also, in comparison with hydroxyproline, real-time PCR and luciferase activity can detect an early increase in fibrosis at day 3 after UUO. From these results, luciferase activity is the best way to evaluate the time course of collagen production of the three. In addition, a luciferase assay, a simple method with only the addition of substrate after homogenization of a sample, needs no special skills and training. Thus, it is less a labor-consuming assay compared with real-time PCR, which requires procedures of RNA extraction, reverse transcription, and PCR. Furthermore, immunostaining with an anti-luciferase antibody, referred to in Figs. 5 and 6, is useful in identifying collagen-producing cells which cause fibrosis. Immunostaining with collagen reveals the localization of collagen, but doesn't reveal the origin cells producing collagen. Also, since luciferase is expressed in all cells in which the collagen gene is natively expressed, we can use transfection-resistant cells, primary culture without differentiation, and organ culture isolated from various tissues for a collagen reporter assay.
The assay using glomeruli isolated from a Col1a1-Luc Tg rat is one of the attractive methods to evaluate fibrosis. Mesangial cells are glomerular-component cells and are generally used for in vitro analysis of the kidney. However, phenotypic changes often occur during culturing as a result of various causes, such as lack of stimuli from other glomerular component cells and stress by a plane culture or subculture. An in vitro assay using isolated glomeruli is an effective way to avoid these problems and allows us to evaluate in a shorter time compared with an assay using cultured cells. Although an assay using isolated glomeruli has a quantitative limitation, the luciferase activity of Col1a1-Luc Tg rats has sufficiently high sensitivity to make this assay practical. TGF-␤ induces type I collagen (27, 30), which is inhibited by ALK5 inhibitors in mesangial cells (30) . Our data in isolated glomeruli of Col1a1-Luc Tg rats corresponded with other data in mesangial cells, indicating that an in vitro assay using isolated glomeruli of Col1a1-LucTg rats is a very effective method for screening antifibrotic drugs and for analyzing the mechanism of their antifibrotic effect.
The renoprotective effects of ARBs have been reported in animals (13, 16, 22, 23) and clinical trials such as RENAAL (7) and IDNT (18) . Their effects are thought to be attributed mainly to two mechanisms, one hemodynamic dependent and the other hemodynamic independent. In this study, ARB had an antifibrotic effect in UUO rats, a hemodynamic-independent tubulointerstitial fibrosis model. ANG II has been reported to directly activate the Smad pathway (25) . However, ANG II had no effect on luciferase activity and ARB had little or no effect on TGF-␤ signaling in this study using isolated glomeruli of Col1a1-Luc Tg rats. Chronic ANG II infusions induce renal interstitial macrophage infiltration in a blood pressure-independent manner (24) , and ANG II increases TGF-␤ expression in renal tubular cells (29) . The antifibrotic effects of ARBs may be mainly attributed to its anti-inflammatory effect by the inhibition of macrophage infiltration and subsequent suppression of TGF-␤ expression. Further elucidation is required to clarify the antifibrotic effect of ARBs.
In conclusion, we generated Col1a1-Luc Tg rats and found them to be very useful animals for the evaluation of fibrosis. By the use of Tg rats, we could detect fibrosis in a short period of time. The immunohistochemistry of luciferase is useful to identify the collagen-producing cells which lead to fibrosis. Furthermore, an in vitro assay using isolated glomeruli is useful to screen antifibrotic agents or to analyze the mechanism of their antifibrotic effects. Research including the use of Col1a1-Luc Tg rats would shed further light on renal fibrosis.
